Renol Polychem Limited (NSE:RNPL)
India · Delayed Price · Currency is INR 64.30
-1.70 (-2.58%)
At close: Oct 23, 2026
Renol Polychem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 899.88 | 622.99 | 64.49 | 416.68 | 267.88 |
Other Revenue | 1.67 | 2.51 | 0.64 | 1.89 | 0.14 |
| 901.55 | 625.5 | 65.14 | 418.57 | 268.02 | |
Revenue Growth | 44.13% | 860.29% | -84.44% | 56.17% | - |
Cost of Revenue | 718.51 | 527.68 | 36.01 | 385.11 | 250.17 |
Gross Profit | 183.05 | 97.82 | 29.13 | 33.45 | 17.85 |
Selling, General & Admin | 23.78 | 5.59 | 1.11 | 1.62 | 1.4 |
Other Operating Expenses | 40.02 | 18.29 | 5.11 | 18.12 | 12.34 |
Operating Expenses | 69.18 | 25.32 | 6.42 | 20.02 | 14.13 |
Operating Income | 113.87 | 72.51 | 22.71 | 13.43 | 3.72 |
Interest Expense | -2.24 | -5.31 | -0.54 | -3.15 | -1.62 |
Interest & Investment Income | 0.2 | 0.12 | 0.09 | 0.01 | 0.01 |
Earnings From Equity Investments | 0.31 | - | - | - | - |
Currency Exchange Gain (Loss) | 0.23 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.62 | -0.68 | -0.48 | -0.47 | -0.03 |
Pretax Income | 111.75 | 66.64 | 21.78 | 9.82 | 2.07 |
Income Tax Expense | 29.2 | 16.67 | 6.44 | 2.53 | 0.49 |
Net Income | 82.55 | 49.97 | 15.34 | 7.28 | 1.58 |
Net Income to Common | 82.55 | 49.97 | 15.34 | 7.28 | 1.58 |
Net Income Growth | 65.20% | 225.76% | 110.67% | 362.29% | - |
Shares Outstanding (Basic) | 12 | 5 | 5 | 7 | - |
Shares Outstanding (Diluted) | 12 | 5 | 5 | 7 | - |
Shares Change | 123.04% | 0.02% | -24.60% | - | - |
EPS (Basic) | 6.74 | 9.10 | 2.79 | 1.00 | - |
EPS (Diluted) | 6.74 | 9.10 | 2.79 | 1.00 | - |
EPS Growth | -25.93% | 226.16% | 179.00% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -625.95 | -13.45 | 12.02 | -11.17 | 2.08 |
Free Cash Flow Per Share | -51.11 | -2.45 | 2.19 | -1.53 | - |
Gross Margin | 20.30% | 15.64% | 44.72% | 7.99% | 6.66% |
Operating Margin | 12.63% | 11.59% | 34.86% | 3.21% | 1.39% |
Profit Margin | 9.16% | 7.99% | 23.55% | 1.74% | 0.59% |
Free Cash Flow Margin | -69.43% | -2.15% | 18.45% | -2.67% | 0.78% |
EBITDA | 119.25 | 73.94 | 22.91 | 13.72 | 4.1 |
EBITDA Margin | 13.23% | 11.82% | 35.17% | 3.28% | 1.53% |
D&A For EBITDA | 5.38 | 1.44 | 0.2 | 0.29 | 0.39 |
EBIT | 113.87 | 72.51 | 22.71 | 13.43 | 3.72 |
EBIT Margin | 12.63% | 11.59% | 34.86% | 3.21% | 1.39% |
Effective Tax Rate | 26.13% | 25.02% | 29.58% | 25.82% | 23.88% |
Revenue as Reported | 902.29 | 625.62 | 65.23 | 418.57 | 268.03 |
Advertising Expenses | 0.08 | 0.13 | - | 0.14 | - |